Greetings! We are pleased to inform you of our transition of kidney health supplement Renadyl to a Live Biotherapeutic Product (LBP) drug category for medical reimbursement reasons. This improved version is known as US APR-2020.
Excellent and Unique Opportunity!
US FDA/CBER Approved RCT
To Delay Dialysis with Probiotics US-APR 2020
Phase 2B, Multi-site CKD Stage 4 (N=630)
Oral and Safe Intestinal Dialysis
In this regard, if you or your friends are interested in exploring the opportunity to be a participant, in this unique clinical trial, please contact the Medical Director at email@example.com.
As we proceed with clinical trials and until the launch of the product as a drug, if you are hesitant to participate you can still avail yourself the opportunity to buy our Kidney health supplement Renadyl™(www.renadyl.com) directly from our online store. If any questions contact our customer service firstname.lastname@example.org or +1.888.271.2560 (US).